Fengying Wu

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

Fengying Wu, Jue Fan, Yayi He et al. · Nature Communications · 2021 · 759 citations · Full text

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · The Lancet Respiratory Medicine · 2020 · 488 citations

Oncology, Clinical Trials, Chemotherapy-naive Patients +9

Lung cancer in China: current and prospect

Fengying Wu, Lei Wang, Caicun Zhou · Current Opinion in Oncology · 2020 · 308 citations

Pyrotinib in <i>HER2</i>-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study

Caicun Zhou, Xingya Li, Qiming Wang et al. · Journal of Clinical Oncology · 2020 · 197 citations

Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers

Tao Jiang, Xiaofeng Xu, Meng Qiao et al. · BMC Cancer · 2018 · 136 citations · Full text